Is this you? Create Your Porfile
Avatar

David G. Nettesheim

University of Wisconsin–Milwaukee

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where David G. Nettesheim is active.

Explore More

Publication

Featured researches published by David G. Nettesheim.

Biochemistry | 2005

Solution structure of human survivin and its binding interface with Smac/Diablo.

Chaohong Sun; David G. Nettesheim; Zhihong Liu; Edward T. Olejniczak

Biochemistry | 1994

NMR determination of the structures of peroxycobalt(III) bleomycin and cobalt(III) bleomycin, products of the aerobic oxidation of cobalt(II) bleomycin by dioxygen.

Robert X. Xu; David G. Nettesheim; James D. Otvos; David H. Petering

Biochemistry | 1992

Sequential Resonance Assignments of Oxidized High-Potential Iron-Sulfur Protein from Chromatium vinosum

David G. Nettesheim; Scott R. Harder; Benjamin A. Feinberg; James D. Otvos

Journal of Biological Chemistry | 1983

Comparative nuclear magnetic resonance studies of high potential iron-sulfur proteins from Chromatium vinosum and Rhodopseudomonas gelatinosa. Additional hyperfine shifted resonances and pH-dependent structural perturbations.

David G. Nettesheim; T E Meyer; B A Feinberg; J D Otvos

Archive | 2004

Inhibitors of Matrix Metalloproteinases

David J. Augeri; David A. Betebenner; Richard A. Craig; Steven K. Davidsen; Stephen W. Fesik; Jamie R. Giesler-Stacey; Yan Guo; Philip J. Hajduk; Michael R. Michaelides; David G. Nettesheim

Journal of Biological Chemistry | 1993

1H NMR-based determination of the three-dimensional structure of the human plasma fibronectin fragment containing inter-chain disulfide bonds.

Leela Kar; Ching San Lai; Carl Wolff; David G. Nettesheim; Simon A. Sherman; Michael E. Johnson

Biochimica et Biophysica Acta | 1980

The role of histidine-42 in the oxidation-reduction mechanism of Chromatium vinosum high potential iron-sulfur protein

David G. Nettesheim; Warren V. Johnson; Benjamin A. Feinberg

Archive | 2001

Mutant peptides derived from bad and their use to identify substances which bind to a member of the bcl-2 family of proteins

Stephen W. Fesik; Robert P. Meadows; Mary K. Joseph; Edward T. Olejniczak; Andrew M. Petros; David G. Nettesheim; Kerry M. Swift; Edmund D. Matayoshi; Haichao Zhang

Archive | 2001

Promoteurs de l'apoptose a base de n-acylsulfonamides

William J. McClellan; Thorsten Oost; Milan Bruncko; Xilu Wang; David J. Augeri; Steven A. Baumeister; Daniel A. Dickman; Hong Ding; Jurgen Dinges; Stephen W. Fesik; Philip J. Hajduk; Aaron R. Kunzer; David G. Nettesheim; Andrew M. Petros; Saul H. Rosenberg; Wang Shen; Sheela A. Thomas; Michael D. Wendt

Archive | 2001

MUTANT BCL-2 PROTEINS AND USES THEREOF

Stephen W. Fesik; Andrew M. Petros; Ho Sup Yoon; David G. Nettesheim

Explore More

Collaboration

Dive into the David G. Nettesheim's collaboration.

Top Co-Authors
Avatar

Stephen W. Fesik

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors
Avatar

Edward T. Olejniczak

Vanderbilt University

View shared research outputs
Top Co-Authors
Avatar

Benjamin A. Feinberg

University of Wisconsin–Milwaukee

View shared research outputs
Top Co-Authors
Avatar

James D. Otvos

North Carolina State University

View shared research outputs
Top Co-Authors
Avatar

Robert X. Xu

Research Triangle Park

View shared research outputs
Top Co-Authors
Avatar

David J. Augeri

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Carl Wolff

Medical College of Wisconsin

View shared research outputs
Top Co-Authors
Avatar

Ching San Lai

Medical College of Wisconsin

View shared research outputs
Top Co-Authors
Avatar

Daniel A. Dickman

Celera Corporation

View shared research outputs
Top Co-Authors
Avatar

David A. Betebenner

Bristol-Myers Squibb

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge